Detalhe da pesquisa
1.
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?
Mov Disord
; 39(2): 294-304, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38006292
2.
Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase.
Mov Disord
; 2024 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38436488
3.
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.
Mov Disord
; 36(5): 1267-1272, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33617695
4.
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.
Int J Mol Sci
; 22(16)2021 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34445626
5.
GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson's Disease.
Int J Mol Sci
; 22(4)2021 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33672321
6.
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol.
BMJ Neurol Open
; 5(2): e000535, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38027469